ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute”

August 15, 1980

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980

Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer”

May 1, 1992

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013